Predicting Major Adverse Events in Patients With Acute Myocardial Infarction

Original Research | By T Nestelberger, J Boeddinghaus, the APACE Investigators et al.

Anticoagulation After Surgical or Transcatheter Bioprosthetic Aortic Valve Replacement

Original Research | By T Chakravarty, A Patel, S Kapadia et al.

A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF)

Original Research | By McMurray JJV, DeMets DL, DAPA-HF Committees and Investigators.

Infective endocarditis after transcatheter aortic valve implantation: a nationwide study

Original Research | By Bjursten H, Rasmussen M, Nozohoor S et al.

Minimizing Permanent Pacemaker Following Repositionable Self-Expanding Transcatheter Aortic Valve Replacement

Original Research | By H Jilaihawi, ZG Zhao, R Du et al.

2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC)

Guideline | By SV Konstantinides, G Meyer, ESC Scientific Document Group

2019 Guidelines on Diabetes, Pre-Diabetes and Cardiovascular Diseases developed in collaboration with the EASD ESC Clinical Practice Guidelines

Guideline | By F Cosentino, PJ Grant, ESC Scientific Document Group et al.

2019 Guidelines on Diabetes, Pre-Diabetes and Cardiovascular Diseases developed in collaboration with the EASD ESC Clinical Practice Guidelines

Guideline | By F Cosentino, PJ Grant, ESC Scientific Document Group et al.

2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes: The Task Force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC)

Guideline | By J Knuuti, W Wijns, ESC Scientific Document Group et al.

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)

Guideline | By F Mach, C Baigent, ESC Scientific Document Group et al.